Related Experiment Videos
Vascular injuries in ergotamine abuse: a case report
V Centonze1, B M Polito, M Di Bari
1Department of Internal Medicine, University of Bari, Italy.
Functional Neurology
|July 1, 1993
Summary
Chronic daily use of ergotamine-containing medication for migraine can lead to serious peripheral vascular complications. This case highlights the risks of long-term ergotamine tartrate, aminophenazone, and caffeine (Virdex) use.
Area of Science:
- Vascular Medicine
- Neurology
Background:
- Migraine is a common neurological disorder.
- Ergotamine tartrate is a medication used for migraine treatment.
Observation:
- A 40-year-old woman with a history of migraine without aura developed limb cramps, paresthesia, and skin pallor.
- She had been using Virdex (ergotamine tartrate, aminophenazone, caffeine) daily for three years.
Findings:
- Instrumental investigations revealed bilateral arterial impairment in the lower limbs.
- This impairment was attributed to chronic ergotamine intake.
Implications:
- This case underscores the potential for severe peripheral vascular complications from chronic ergotamine use.
- It emphasizes the need for careful monitoring of patients on long-term ergotamine therapy.
- Alternative migraine management strategies should be considered for long-term treatment.